Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Angelini Pharma commits to Lumira-managed funds

The Angelini Lumira Biosciences Fund will invest in early-stage companies in Canada and the US.


Aug 7, 2021

Daily Deal Round Up: August 6, 2021

JD Health has backed a $93m series D round for Rimag, while a couple of India-based startups delivered exits.

Aug 6, 2021

Hopin hatches $450m series D plan

Salesforce and Slack were among a consortium of new and existing backers for Hopin’s series D round, which comes only five months after a $400m series C.

Aug 6, 2021

Bukalapak packs up $7.6bn market cap

The Ant Group, Aucfan, Emtek, Gree, Microsoft and Naver-backed digital marketplace owner’s shares on IDX jumped 25% on the first day of trading.

Aug 6, 2021

Deere undertakes Bear Flag purchase

John Deere is paying $250m to buy the AgFunder-backed self-driving tractor system developer.

Aug 6, 2021

MindTickle wins $100m at $1.2bn valuation

The sales training software developer has now raised $281m in total, with SoftBank and Qualcomm returning for its series E round.

Aug 6, 2021

Joinn Biologics enters $150m series B

The China Union-backed drug contract manufacturer has raised the funding approximately a year and a half after a $60m series A.

Aug 6, 2021

V2Food has series B seconds

Main Sequence Ventures has contributed to a $53.3m series B-plus for V2Food, having already backed the initial $55m series B round last October.

Aug 6, 2021

Trimble constructs $200m corporate venturing fund

The engineering technology provider’s newly formed Trimble Ventures unit will target startups and scale-ups working on technologies strategic to its existing industrial businesses.

Aug 5, 2021

FullStory goes on with $103m series D

GV, Dell Technologies Capital and Salesforce Ventures have all returned to back the digital experience tracking service’s latest round, which valued it at $1.8bn.

Aug 5, 2021

Bayer to buy Vividion for $1.5bn

Bayer is set to acquire the precision therapeutics developer backed by Alexandria Venture Investments, Celgene and SoftBank, with another $500m in milestone payments up for grabs.

Aug 5, 2021

Emerging Leaders Q&A – Antoine Delafargue, TCNV

Q&A with Antoine Delafargue, MD & CTO, Total Carbon Neutrality Ventures

Aug 5, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here